SELLAS Life Sciences Group Statistics
NASDAQ: SLSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
11.31-0.03 (-0.26%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 11.34 +0.27%
SELLAS Life Sciences Group by the numbers
SELLAS Life Sciences Group has a market capitalization of $2.28 billion based on 201.95M shares outstanding. With trailing EPS of $-0.21, SELLAS Life Sciences Group is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.3% below its 50-day average and 43.6% above its 200-day average.
Average daily trading volume is 6.75M shares, or about $76.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SLS valuation vs. peer median
| Metric | SLS | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.28B | $2.30B | -1% |
| Avg. volume | 6.75M | 1.05M | +543% |
Peer median across 8 companies: HRMY, BHC, PBH, IMNM, IRON, PHVS, NRIX, LQDA.
Valuation
- Market cap
- $2.28B
- EPS (TTM)
- $-0.21
- Shares outstanding
- 201.95M
Price and trading
- Previous close
- 11.34
- Open
- 11.26
- Day range
- 11.15 – 11.54
- 52-week range
- 1.39 – 15.88
- 52-week change
- +495.26%
- Beta
- —
- Volume
- 3.13M
- Average volume
- 6.75M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 11, 2026
Additional statistics
- Market Cap
- 2.28B
- Forward Pe
- -113.10
- Eps
- -0.21
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 15.88
- Week52 Low
- 1.39
- Avg Volume
- 6.75M
- Shares Outstanding
- 201.95M
- Ma50
- 12.33
- Ma200
- 7.87
- Earnings Date
- Nov 11, 2026
- Pct From52w High
- -28.78%
- Pct From52w Low
- 713.67%